Pigment epithelium-derived factor (PEDF) inhibits collagen-induced platelet activation by reducing intraplatelet nitrotyrosine levels

International Journal of Cardiology

Volumn 140, Issue 1, 2010, Pages 121-122

  Yamagishi, Sho ichi ^a   Matsui, Takanori ^a   Nakamura, Kazuo ^a   Takenaka, Katsuhiko ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Nitrotyrosine; PDGF; PEDF; Platelet activation

Indexed keywords

3 NITROTYROSINE; COLLAGEN; NITRIC OXIDE; PEROXYNITRITE; PIGMENT EPITHELIUM DERIVED FACTOR; PLATELET DERIVED GROWTH FACTOR AB;

ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA;

BLOOD PLATELETS; EYE PROTEINS; NERVE GROWTH FACTORS; NITRIC OXIDE; PLATELET ACTIVATION; PROTEASE INHIBITORS; SERPINS; TYROSINE;

EID: 77949490704     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.11.015     Document Type: Article

References (11)

1. Tombran-Tink J., and Barnstable C.J. PEDF: a multifaceted neurotropic factor. Nat Rev Neurosci 4 (2003) 628-636
2. Yamagishi S., Nakamura K., Matsui T., Inagaki Y., Takenaka K., Jinnouchi Y., et al. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem 281 (2006) 20213-20220
3. Nakamura K., Yamagishi S., Matsui T., Yoshida T., Takenaka K., Jinnouchi Y., et al. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation. Am J Pathol 170 (2007) 2159-2170
4. Takenaka K., Yamagishi S., Matsui T., Nakamura K., Jinnouchi Y., Yoshida Y., et al. Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: a possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes. Atherosclerosis 197 (2008) 25-33
5. Sase K., and Michel T. Expression of constitutive endothelial nitric oxide synthase in human blood platelets. Life Sci 57 (1995) 2049-2055
6. Gkaliagkousi E., Ritter J., and Ferro A. Platelet-derived nitric oxide signaling and regulation. Circ Res 101 (2007) 654-662
7. Olas B., and Wachowicz B. Role of reactive nitrogen species in blood platelet functions. Platelets 18 (2007) 555-565
8. Redondo P.C., Jardin I., Hernández-Cruz J.M., Pariente J.A., Salido G.M., and Rosado J.A. Hydrogen peroxide and peroxynitrite enhance Ca2+ mobilization and aggregation in platelets from type 2 diabetic patients. Biochem Biophys Res Commun 333 (2005) 794-802
9. Yamagishi S., Inagaki Y., Amano S., Okamoto T., Takeuchi M., and Makita Z. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end products-induced injury through its antioxidative properties. Biochem Biophys Res Commun 296 (2002) 877-882
10. Morita H., Ikeda H., Haramaki N., Eguchi H., and Imaizumi T. Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers. J Am Coll Cardiol 45 (2005) 589-594
11. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150